News - Rest of the World

Filter

Current filters:

Rest of the World

Popular Filters

54 to 78 of 160 results

Teva and Lonza to discontinue their biosimilars collaboration

25-07-2013

Israel-based Teva Pharmaceuticals Industries (NYSE: TEVA), the world's leading generics drugmaker, and…

GenericsLonzaMergers & AcquisitionsRest of the WorldTeva Pharmaceutical Industries

A growing market for pharmaceuticals in Iran

23-07-2013

Iran's spending on pharmaceuticals is forecast to reach $4.14 billion by 2019, according to market insight…

Markets & MarketingPharmaceuticalRest of the World

Greater generic drug penetration could reduce private health care cost in South Africa

18-07-2013

Recently, two of the larger hospital groups in South Africa, Netcare and Mediclinic, called for the Competition…

FinancialGenericsHealthcareMarkets & MarketingRest of the World

Auxilium and SOBI collaborate on Xiapex

16-07-2013

USA-based Auxilium Pharmaceuticals (Nasdaq: AUXL) and Swedish Orphan Biovitrum (STO: SOBI) have entered…

Auxilium PharmaceuticalsEuropeLicensingPharmaceuticalRare diseasesRest of the WorldSwedish Orphan BiovitrumXiapex

Less than 30% of drugs in Nigeria made locally

15-07-2013

Last week, the Director General, of Nigeria's National Agency for Foods, Drugs Administration and Control,…

GenericsMarkets & MarketingPharmaceuticalProductionRest of the World

Hikma licenses Vibativ from Theravance for MENA region

02-07-2013

Jordon-headquartered Hikma Pharmaceuticals (LSE: HIK) says it has signed an exclusive commercialization…

Antibiotics and Infectious diseasesHikma PharmaceuticalsLicensingPharmaceuticalRest of the WorldTheravanceVibativ

Meda expands collaboration with India's Cipla on Dymista

06-06-2013

Swedish drugmaker Meda (OMX: MEDA A) is broadening its collaboration with Indian pharmaceutical company…

Asia-PacificCiplaDymistaLicensingMedaPharmaceuticalRespiratory and PulmonaryRest of the WorldSouth America

Switzerland's Lonza involvement in South Africa pharma project in doubt

28-05-2013

The South Africa government is expected to publish a request for information from potential international,…

Anti-viralsGenericsLonzaNovartisProductionRest of the World

Brazilian pharma exports to GCC up 73% to reach over $7.4 million in 2012

13-05-2013

Brazil exported $7.48 million worth of pharmaceutical products to the Gulf Cooperation Council (GCC)…

GenericsMarkets & MarketingPharmaceuticalRest of the WorldSouth America

Africa's pharmaceutical industry faces numerous challenges, VoA reports

13-05-2013

Providing Africans with affordable health care could be realized if pharmaceutical products were produced…

Asia-PacificGenericsHealthcarePharmaceuticalProductionRest of the World

Merck & Co's Gardasil and GSK's Cervarix to be available to developing countries via UNICEF tender

09-05-2013

A new record low price for human papillomavirus (HPV) vaccines will help ensure millions of girls in…

CervarixGardasilGlaxoSmithKlineHealthcareMerck & CoOncologyPharmaceuticalPricingRest of the World

GCC pharmaceutical market forecast to exceed $10 billion by 2020

11-04-2013

The Gulf Cooperation Council (GCC)'s market for European-made drugs and medicines is expected to pass…

Laboratorios CinfaMarkets & MarketingPharmaceuticalRest of the World

Mumtalakat accord with SBI Pharma for manufacturing plant in Bahrain

22-03-2013

Bahrain Mumtalakat Holding Co, the investment arm of Bahrain, has signed an agreement with Japanese firm…

Mumtalakat HoldingPharmaceuticalProductionRest of the WorldSBI Pharmaceuticals

Experts to examine opportunities in growing African pharmaceutical market

12-03-2013

"At a time when growth in traditional pharmaceutical markets is stalling, strong macroeconomic fundamentals…

GenericsMarkets & MarketingPharmaceuticalRegulationRest of the World

Anti-infective market in sub-Saharan Africa set to reach $377 million in 2018

05-03-2013

The high incidence of infectious diseases in sub-Saharan Africa is expected to sustain the demand for…

Antibiotics and Infectious diseasesGenericsMarkets & MarketingPharmaceuticalRest of the World

Mylan debuts HIV/AIDS drug portfolio in South Africa

24-02-2013

US generics company Mylan (Nasdaq: MYL) says that its subsidiary in South Africa has launched a comprehensive…

Anti-viralsGenericsMarkets & MarketingMylan LaboratoriesRest of the World

Change in US CBO's projections of spending for Medicare and Medicaid

24-02-2013

In its most recent baseline projections, the USA's Congressional Budget Office (CBO) reduced its estimates…

FinancialHealthcarePharmaceuticalRest of the World

South African pharma market set to grow to $7 billion in 2018

19-02-2013

South Africa's pharmaceutical market is one of the most attractive markets in Africa. Some of the main…

GenericsMarkets & MarketingPharmaceuticalRegulationRest of the World

Cipla prevails in Sutent patent dispute with Pfizer; puts hold on Cipla Medpro deal

12-02-2013

The Indian patent office has again ruled in favor of domestic drugmaker Cipla (BSE: 500087), reinstating…

Asia-PacificCiplaCipla MedproGenericsLegalMergers & AcquisitionsOncologyPatentsPfizerRest of the WorldSutent

Dramatic drop in US pharma exports to Iran

11-02-2013

The US Department of Commerce has recently released data, showing that exports of pharmaceutical products…

FinancialMarkets & MarketingPharmaceuticalPoliticsRest of the World

Julphar inaugurates drug-making plant in Ethiopia; discusses UAE drug prices

10-02-2013

In recognition of the economic importance of Africa and the need for increasingly sophisticated pharmaceutical…

GenericsJulpharPharmaceuticalPricingProductionRest of the World

GAVI Alliance funds vaccines for cervical cancer in developing countries

08-02-2013

More than 180,000 girls in eight developing countries are set to receive protection against the leading…

CervarixGardasilGlaxoSmithKlineHealthcareMerck & CoPharmaceuticalRest of the WorldVaccinesWomen's Health

54 to 78 of 160 results

Back to top